Carolyn F. Deacon

Carolyn F. Deacon

Associate Professor


  1. 2005
  2. Published

    Neutral Endopeptidase 24.11 and dipeptidyl peptidase IV are both physiological mediators of the degradation of glucagon-like peptide-1 in the anaesthetized pig. / Plamboeck, A.; Holst, J.J.; Carr, R.D.; Deacon, C.F.

    In: Diabetologia, No. 48, 2005, p. 1882-1890.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Normal secretion and action of the gut incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in young men with low birth weight. / Schou, Jakob Hagen; Pilgaard, Kasper; Vilsbøll, Tina; Jensen, Christine B; Deacon, Carolyn F; Holst, Jens Juul; Vølund, Aage; Madsbad, Sten; Vaag, Allan A.

    In: Journal of Clinical Endocrinology and Metabolism, Vol. 90, No. 8, 2005, p. 4912-19.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Sensory nerve desensitization by resiniferatoxin improves glucose tolerance and increases insulin secretion in Zucker Diabetic Fatty rats and is associated with reduced plasma activity of dipeptidyl peptidase IV. / Gram, Dorte X; Hansen, Anker J; Deacon, Carolyn F; Brand, Christian L; Ribel, Ulla; Wilken, Michael; Carr, Richard D; Svendsen, Ove; Ahrén, Bo.

    In: European Journal of Pharmacology, Vol. 509, No. 2-3, 2005, p. 211-7.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    The incretin enhancer vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed -cell function in patients with type 2 diabetes. / Mari, A.; Sallas, W.M.; He, Y.L.; Watson, C.; Ligueros-Saylan, M.; Dunning, B.E.; Deacon, Carolyn F.; Holst, Jens Juul; Foley, J.E.

    In: Journal of Clinical Endocrinology and Metabolism, No. 90, 2005, p. 4888-4894.

    Research output: Contribution to journalJournal articleResearch

  6. Published

    Vildagliptin, a dipeptidyl peptidase-IV inhibitor improves model-assessed beta-cell function in patients with type 2 diabetes. / Mari, A.; Sallas, W.M.; He, Y.L.; Watson, C.; Ligueros-Saylan, M.; Duning, B.E.; Deacon, Carolyn F.; Holst, Jens Juul; Foley, J.E.

    In: J. Clin. Endocrinol. Metab., No. 90, 2005, p. 4888-4894.

    Research output: Contribution to journalJournal articleResearch

  7. Published

    What do we know about the secretion and degradation of incretin hormones? / Deacon, Carolyn F.

    In: Regulatory Peptides, Vol. 128, No. 2, 2005, p. 117-24.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. 2004
  9. Published

    Circulation and degradation of GIP and GLP-1. / Deacon, Carolyn F.

    In: Hormone and Metabolic Research, No. 36, 2004, p. 761-765.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitus. / Holst, Jens Juul; Deacon, Carolyn F.

    In: Current Opinion in Pharmacology, Vol. 4, No. 6, 2004, p. 589-96.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Inhibitors of dipeptidyl peptidase IV: a novel approach for the prevention and treatment of Type 2 diabetes? / Deacon, Carolyn F; Ahrén, Bo; Holst, Jens J.

    In: Expert Opinion on Investigational Drugs, Vol. 13, No. 9, 2004, p. 1091-102.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Neutral endopeptidase 24.11 is important for the degradation of both endogenous and exogenous glucagon in anesthetized pigs. / Trebbien, Ramona; Klarskov, Letty; Olesen, Mette; Holst, Jens J; Carr, Richard D; Deacon, Carolyn F.

    In: American Journal of Physiology: Endocrinology and Metabolism, Vol. 287, No. 3, 2004, p. E431-8.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 9220